Valley
US$ 27.65
glucagon glp-1 Glucagon-like peptide-1 Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
2-4 Patients may experience facial changes such as dry, dull or sagging skin, a gaunt or hollowed-out facial appearance, or other unwelcome alterations to facial structure and balance
What is a GLP- 1 Agonist and how do they work
Poor blood sugar regulation may play a role
It is important to note that some individuals on Ozempic may experience reduced appetite or nausea, which can make dietary changes challenging
